Loading…

Synthesis and Characterization of PCL-Idebenone Nanoparticles for Potential Nose-to-Brain Delivery

The present work is focused on the preparation of an optimal model of poly-ε-caprolactone nanoparticles as potential carriers for nasal administration of idebenone. A solvent/evaporation technique was used for nanoparticle preparation. Poly-ε-caprolactone with different molecular weights (14,000 and...

Full description

Saved in:
Bibliographic Details
Published in:Biomedicines 2023-05, Vol.11 (5), p.1491
Main Authors: Boyuklieva, Radka, Hristozova, Asya, Pilicheva, Bissera
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c570t-2959e86816902c6b342415502d203486d12110a1211209beca7b0b43e99a5a5f3
cites cdi_FETCH-LOGICAL-c570t-2959e86816902c6b342415502d203486d12110a1211209beca7b0b43e99a5a5f3
container_end_page
container_issue 5
container_start_page 1491
container_title Biomedicines
container_volume 11
creator Boyuklieva, Radka
Hristozova, Asya
Pilicheva, Bissera
description The present work is focused on the preparation of an optimal model of poly-ε-caprolactone nanoparticles as potential carriers for nasal administration of idebenone. A solvent/evaporation technique was used for nanoparticle preparation. Poly-ε-caprolactone with different molecular weights (14,000 and 80,000 g/mol) was used. Polysorbate 20 and Poloxamer 407, alone and in combination, were used as emulsifiers at different concentrations to obtain a stable formulation. The nanoparticles were characterized using dynamic light scattering, SEM, TEM, and FTIR. The resulting structures were spherical in shape and their size distribution depended on the type of emulsifier. The average particle size ranged from 188 to 628 nm. The effect of molecular weight and type of emulsifier was established. Optimal models of appropriate size for nasal administration were selected for inclusion of idebenone. Three models of idebenone-loaded nanoparticles were developed and the effect of molecular weight on the encapsulation efficiency was investigated. Increased encapsulation efficiency was found when poly-ε-caprolactone with lower molecular weight was used. The molecular weight also affected the drug release from the nanostructures. Dissolution study data were fitted into various kinetic models and the Korsmeyer-Peppas model was found to be indicative of the release mechanism of idebenone.
doi_str_mv 10.3390/biomedicines11051491
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_d6485bca3aef401b9cac0127b96dc575</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A750887776</galeid><doaj_id>oai_doaj_org_article_d6485bca3aef401b9cac0127b96dc575</doaj_id><sourcerecordid>A750887776</sourcerecordid><originalsourceid>FETCH-LOGICAL-c570t-2959e86816902c6b342415502d203486d12110a1211209beca7b0b43e99a5a5f3</originalsourceid><addsrcrecordid>eNptUl1vEzEQPCEQrUr_AUIn8cLLFX-cz-cnVFIokaJSCXi21r69xNHFDvalUvj1OE2oElRbsq31zHhnvUXxlpIrzhX5aFxYYees85goJYLWir4ozhljslJEqJdH57PiMqUlyUNR3tL6dXHGJeOKNvS8MD-2flxgcqkE35WTBUSwI0b3B0YXfBn68n4yq6YdGvTBY3kHPqwhjs4OmMo-xPI-jOhHB0N5FxJWY6g-R3C-vMHBPWDcvile9TAkvDzsF8Wvr19-Tr5Vs--308n1rLJCkrFiSihsm5Y2ijDbGF6zmgpBWMcIr9umoyw7hd3KiDJoQRpiao5KgQDR84tiutftAiz1OroVxK0O4PRjIMS5PuStu6ZuhbHAAfuaUKMsWEKZNKrpcjYia33aa603JhfaZoMRhhPR0xvvFnoeHjQljGYPO4UPB4UYfm8wjXrlksVhAI9hkzRrGSG0EbLO0Pf_QZdhE32uVUZRxaXizRFqDtmB833ID9udqL6WgrStlLLJqKtnUHl2uHI2f2DvcvyEUO8JNoaUIvZPJinRu17Tz_Vapr07LtAT6V9n8b97F9Cb</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2819379364</pqid></control><display><type>article</type><title>Synthesis and Characterization of PCL-Idebenone Nanoparticles for Potential Nose-to-Brain Delivery</title><source>Publicly Available Content Database</source><source>PubMed</source><creator>Boyuklieva, Radka ; Hristozova, Asya ; Pilicheva, Bissera</creator><creatorcontrib>Boyuklieva, Radka ; Hristozova, Asya ; Pilicheva, Bissera</creatorcontrib><description>The present work is focused on the preparation of an optimal model of poly-ε-caprolactone nanoparticles as potential carriers for nasal administration of idebenone. A solvent/evaporation technique was used for nanoparticle preparation. Poly-ε-caprolactone with different molecular weights (14,000 and 80,000 g/mol) was used. Polysorbate 20 and Poloxamer 407, alone and in combination, were used as emulsifiers at different concentrations to obtain a stable formulation. The nanoparticles were characterized using dynamic light scattering, SEM, TEM, and FTIR. The resulting structures were spherical in shape and their size distribution depended on the type of emulsifier. The average particle size ranged from 188 to 628 nm. The effect of molecular weight and type of emulsifier was established. Optimal models of appropriate size for nasal administration were selected for inclusion of idebenone. Three models of idebenone-loaded nanoparticles were developed and the effect of molecular weight on the encapsulation efficiency was investigated. Increased encapsulation efficiency was found when poly-ε-caprolactone with lower molecular weight was used. The molecular weight also affected the drug release from the nanostructures. Dissolution study data were fitted into various kinetic models and the Korsmeyer-Peppas model was found to be indicative of the release mechanism of idebenone.</description><identifier>ISSN: 2227-9059</identifier><identifier>EISSN: 2227-9059</identifier><identifier>DOI: 10.3390/biomedicines11051491</identifier><identifier>PMID: 37239161</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Alzheimer's disease ; Antioxidants ; Bioavailability ; Efficiency ; Emulsifiers ; Encapsulation ; Evaporation ; Hypoxia ; idebenone ; Inflammation ; Intranasal administration ; Light scattering ; Molecular weight ; Morphology ; Nanoparticles ; nose-to-brain delivery ; Oxidative stress ; Parkinson's disease ; Particle size ; poly-ε-caprolactone ; Polycaprolactone ; Polymers ; Scanning electron microscopy ; Size distribution ; Spectrum analysis ; Surface active agents</subject><ispartof>Biomedicines, 2023-05, Vol.11 (5), p.1491</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c570t-2959e86816902c6b342415502d203486d12110a1211209beca7b0b43e99a5a5f3</citedby><cites>FETCH-LOGICAL-c570t-2959e86816902c6b342415502d203486d12110a1211209beca7b0b43e99a5a5f3</cites><orcidid>0000-0001-5348-9805 ; 0000-0002-5737-536X ; 0000-0001-8594-1712</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2819379364/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2819379364?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,44569,53769,53771,74872</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37239161$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boyuklieva, Radka</creatorcontrib><creatorcontrib>Hristozova, Asya</creatorcontrib><creatorcontrib>Pilicheva, Bissera</creatorcontrib><title>Synthesis and Characterization of PCL-Idebenone Nanoparticles for Potential Nose-to-Brain Delivery</title><title>Biomedicines</title><addtitle>Biomedicines</addtitle><description>The present work is focused on the preparation of an optimal model of poly-ε-caprolactone nanoparticles as potential carriers for nasal administration of idebenone. A solvent/evaporation technique was used for nanoparticle preparation. Poly-ε-caprolactone with different molecular weights (14,000 and 80,000 g/mol) was used. Polysorbate 20 and Poloxamer 407, alone and in combination, were used as emulsifiers at different concentrations to obtain a stable formulation. The nanoparticles were characterized using dynamic light scattering, SEM, TEM, and FTIR. The resulting structures were spherical in shape and their size distribution depended on the type of emulsifier. The average particle size ranged from 188 to 628 nm. The effect of molecular weight and type of emulsifier was established. Optimal models of appropriate size for nasal administration were selected for inclusion of idebenone. Three models of idebenone-loaded nanoparticles were developed and the effect of molecular weight on the encapsulation efficiency was investigated. Increased encapsulation efficiency was found when poly-ε-caprolactone with lower molecular weight was used. The molecular weight also affected the drug release from the nanostructures. Dissolution study data were fitted into various kinetic models and the Korsmeyer-Peppas model was found to be indicative of the release mechanism of idebenone.</description><subject>Alzheimer's disease</subject><subject>Antioxidants</subject><subject>Bioavailability</subject><subject>Efficiency</subject><subject>Emulsifiers</subject><subject>Encapsulation</subject><subject>Evaporation</subject><subject>Hypoxia</subject><subject>idebenone</subject><subject>Inflammation</subject><subject>Intranasal administration</subject><subject>Light scattering</subject><subject>Molecular weight</subject><subject>Morphology</subject><subject>Nanoparticles</subject><subject>nose-to-brain delivery</subject><subject>Oxidative stress</subject><subject>Parkinson's disease</subject><subject>Particle size</subject><subject>poly-ε-caprolactone</subject><subject>Polycaprolactone</subject><subject>Polymers</subject><subject>Scanning electron microscopy</subject><subject>Size distribution</subject><subject>Spectrum analysis</subject><subject>Surface active agents</subject><issn>2227-9059</issn><issn>2227-9059</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUl1vEzEQPCEQrUr_AUIn8cLLFX-cz-cnVFIokaJSCXi21r69xNHFDvalUvj1OE2oElRbsq31zHhnvUXxlpIrzhX5aFxYYees85goJYLWir4ozhljslJEqJdH57PiMqUlyUNR3tL6dXHGJeOKNvS8MD-2flxgcqkE35WTBUSwI0b3B0YXfBn68n4yq6YdGvTBY3kHPqwhjs4OmMo-xPI-jOhHB0N5FxJWY6g-R3C-vMHBPWDcvile9TAkvDzsF8Wvr19-Tr5Vs--308n1rLJCkrFiSihsm5Y2ijDbGF6zmgpBWMcIr9umoyw7hd3KiDJoQRpiao5KgQDR84tiutftAiz1OroVxK0O4PRjIMS5PuStu6ZuhbHAAfuaUKMsWEKZNKrpcjYia33aa603JhfaZoMRhhPR0xvvFnoeHjQljGYPO4UPB4UYfm8wjXrlksVhAI9hkzRrGSG0EbLO0Pf_QZdhE32uVUZRxaXizRFqDtmB833ID9udqL6WgrStlLLJqKtnUHl2uHI2f2DvcvyEUO8JNoaUIvZPJinRu17Tz_Vapr07LtAT6V9n8b97F9Cb</recordid><startdate>20230522</startdate><enddate>20230522</enddate><creator>Boyuklieva, Radka</creator><creator>Hristozova, Asya</creator><creator>Pilicheva, Bissera</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-5348-9805</orcidid><orcidid>https://orcid.org/0000-0002-5737-536X</orcidid><orcidid>https://orcid.org/0000-0001-8594-1712</orcidid></search><sort><creationdate>20230522</creationdate><title>Synthesis and Characterization of PCL-Idebenone Nanoparticles for Potential Nose-to-Brain Delivery</title><author>Boyuklieva, Radka ; Hristozova, Asya ; Pilicheva, Bissera</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c570t-2959e86816902c6b342415502d203486d12110a1211209beca7b0b43e99a5a5f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Alzheimer's disease</topic><topic>Antioxidants</topic><topic>Bioavailability</topic><topic>Efficiency</topic><topic>Emulsifiers</topic><topic>Encapsulation</topic><topic>Evaporation</topic><topic>Hypoxia</topic><topic>idebenone</topic><topic>Inflammation</topic><topic>Intranasal administration</topic><topic>Light scattering</topic><topic>Molecular weight</topic><topic>Morphology</topic><topic>Nanoparticles</topic><topic>nose-to-brain delivery</topic><topic>Oxidative stress</topic><topic>Parkinson's disease</topic><topic>Particle size</topic><topic>poly-ε-caprolactone</topic><topic>Polycaprolactone</topic><topic>Polymers</topic><topic>Scanning electron microscopy</topic><topic>Size distribution</topic><topic>Spectrum analysis</topic><topic>Surface active agents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boyuklieva, Radka</creatorcontrib><creatorcontrib>Hristozova, Asya</creatorcontrib><creatorcontrib>Pilicheva, Bissera</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Biomedicines</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boyuklieva, Radka</au><au>Hristozova, Asya</au><au>Pilicheva, Bissera</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and Characterization of PCL-Idebenone Nanoparticles for Potential Nose-to-Brain Delivery</atitle><jtitle>Biomedicines</jtitle><addtitle>Biomedicines</addtitle><date>2023-05-22</date><risdate>2023</risdate><volume>11</volume><issue>5</issue><spage>1491</spage><pages>1491-</pages><issn>2227-9059</issn><eissn>2227-9059</eissn><abstract>The present work is focused on the preparation of an optimal model of poly-ε-caprolactone nanoparticles as potential carriers for nasal administration of idebenone. A solvent/evaporation technique was used for nanoparticle preparation. Poly-ε-caprolactone with different molecular weights (14,000 and 80,000 g/mol) was used. Polysorbate 20 and Poloxamer 407, alone and in combination, were used as emulsifiers at different concentrations to obtain a stable formulation. The nanoparticles were characterized using dynamic light scattering, SEM, TEM, and FTIR. The resulting structures were spherical in shape and their size distribution depended on the type of emulsifier. The average particle size ranged from 188 to 628 nm. The effect of molecular weight and type of emulsifier was established. Optimal models of appropriate size for nasal administration were selected for inclusion of idebenone. Three models of idebenone-loaded nanoparticles were developed and the effect of molecular weight on the encapsulation efficiency was investigated. Increased encapsulation efficiency was found when poly-ε-caprolactone with lower molecular weight was used. The molecular weight also affected the drug release from the nanostructures. Dissolution study data were fitted into various kinetic models and the Korsmeyer-Peppas model was found to be indicative of the release mechanism of idebenone.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>37239161</pmid><doi>10.3390/biomedicines11051491</doi><orcidid>https://orcid.org/0000-0001-5348-9805</orcidid><orcidid>https://orcid.org/0000-0002-5737-536X</orcidid><orcidid>https://orcid.org/0000-0001-8594-1712</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2227-9059
ispartof Biomedicines, 2023-05, Vol.11 (5), p.1491
issn 2227-9059
2227-9059
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_d6485bca3aef401b9cac0127b96dc575
source Publicly Available Content Database; PubMed
subjects Alzheimer's disease
Antioxidants
Bioavailability
Efficiency
Emulsifiers
Encapsulation
Evaporation
Hypoxia
idebenone
Inflammation
Intranasal administration
Light scattering
Molecular weight
Morphology
Nanoparticles
nose-to-brain delivery
Oxidative stress
Parkinson's disease
Particle size
poly-ε-caprolactone
Polycaprolactone
Polymers
Scanning electron microscopy
Size distribution
Spectrum analysis
Surface active agents
title Synthesis and Characterization of PCL-Idebenone Nanoparticles for Potential Nose-to-Brain Delivery
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T18%3A57%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20Characterization%20of%20PCL-Idebenone%20Nanoparticles%20for%20Potential%20Nose-to-Brain%20Delivery&rft.jtitle=Biomedicines&rft.au=Boyuklieva,%20Radka&rft.date=2023-05-22&rft.volume=11&rft.issue=5&rft.spage=1491&rft.pages=1491-&rft.issn=2227-9059&rft.eissn=2227-9059&rft_id=info:doi/10.3390/biomedicines11051491&rft_dat=%3Cgale_doaj_%3EA750887776%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c570t-2959e86816902c6b342415502d203486d12110a1211209beca7b0b43e99a5a5f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2819379364&rft_id=info:pmid/37239161&rft_galeid=A750887776&rfr_iscdi=true